Morgan Stanley analyst Mark Purcell raised the firm’s price target on Novo Nordisk to DKK 990 from DKK 930 and keeps an Overweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
